Copertina

CRISPLD2, a novel insulin‐sensitizing adipokine that alters adipocyte size

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Beth A. Griesel, Kylie Williams, Nagib Ahsan, Philipp E. Scherer, Ann Louise Olson, David P. Sparling
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Obesity
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Adipose Tissue Analysis Toolkit (ATAT) for automated analysis of adipocyte size and extracellular matrix in white adipose tissue
di: Jacob J. Robino, et al.
Pubblicazione: (2024)

CRISPLD2 : A Weight Loss‐Induced Adipokine With Antifibrotic Capabilities in Adipose Tissue
di: David Mendoza, et al.
Pubblicazione: (2025)

Effects of weight loss on testosterone, sex hormone‐binding globulin, adiposity, and insulin sensitivity in women and men
di: Justine M. Mucinski, et al.
Pubblicazione: (2025)

Loss of VSTM2A promotes adipocyte hypertrophy and disrupts metabolic homeostasis
di: Manal Al Dow, et al.
Pubblicazione: (2025)

Regulation of the terminal complement cascade in adipose tissue for control of its volume, cellularity, and fibrosis
di: Ilja L. Kruglikov, et al.
Pubblicazione: (2025)

Dual action of imeglimin on insulin secretion and sensitivity in type 2 diabetes
di: Tsubasa Tajima, et al.
Pubblicazione: (2026)

Obstructive sleep apnea is associated with impaired insulin clearance and hepatic insulin sensitivity in paediatric obesity
di: Giuseppina Rosaria Umano, et al.
Pubblicazione: (2025)

Comment on “adipokines and stroke: A systematic review and meta‐analysis of disease risk and patient outcomes”
di: Lang Li, et al.
Pubblicazione: (2025)

Effect of insulin sensitivity, insulin secretion, and beta cell function on the remission of type 2 diabetes: A post hoc analysis of the IDEATE trial
di: Xianglin Wu, et al.
Pubblicazione: (2025)

The impact of a low‐carbohydrate (vs. low‐fat) diet on fat mass loss in African American women is modulated by insulin sensitivity
di: Catia Martins, et al.
Pubblicazione: (2025)

Menopause factors and alterations in gut microbiota and insulin homeostasis: A cross‐sectional analysis of the microbiome and insulin longitudinal evaluation study ( MILES )
di: Vincent J. Maffei, et al.
Pubblicazione: (2025)

Intermediate versus morning chronotype has lower vascular insulin sensitivity in adults with obesity
di: Steven K. Malin, et al.
Pubblicazione: (2024)

Lipids and adipocytes involvement in tumor progression with a focus on obesity and diet
di: Chiara Calabrese, et al.
Pubblicazione: (2024)

Carnitine supplementation improves insulin sensitivity and skeletal muscle acetylcarnitine formation in patients with type 2 diabetes
di: Yvonne M. H. Op den Kamp‐Bruls, et al.
Pubblicazione: (2025)

No evidence from euglycaemic–hyperinsulinaemic clamp studies for greater insulin sensitivity in adults with type 1 diabetes using insulin pump versus multiple daily insulin injections—Post hoc meta‐analysis
di: Andrzej S. Januszewski, et al.
Pubblicazione: (2025)

Acidosis is associated with lower insulin sensitivity and incident type 2 diabetes in indigenous Americans: A prospective cohort study
di: Andrés M. Treviño‐Alvarez, et al.
Pubblicazione: (2025)

Relationship of receptors of adipokines with hypertension and obesity. Murine model
di: Teresa Pérez-Capistran
Pubblicazione: (2017)

Metformin attenuates metabolic insulin sensitivity and insulin‐stimulated carbohydrate oxidation after high‐intensity exercise training in adults at risk for metabolic syndrome
di: Steven K. Malin, et al.
Pubblicazione: (2026)

Ethnic differences in the relationship between ectopic fat deposition and insulin sensitivity in Black African and White European men across a spectrum of glucose tolerance
di: Gráinne Whelehan, et al.
Pubblicazione: (2024)

Fructose restriction has beneficial effects on adipose tissue distribution but not on serum adipokine levels: Post‐hoc analysis of a double‐blind randomized controlled trial
di: Michelle A. J. van Oeteren, et al.
Pubblicazione: (2024)

Brd9 antagonism induces beige adipocytes in white adipose tissues and protects against diet‐induced obesity
di: Yang Liu, et al.
Pubblicazione: (2025)

Changes in insulin sensitivity and gut peptides 8 and 52 weeks after bariatric surgery or low‐calorie diet
di: Adam C. Lowe, et al.
Pubblicazione: (2024)

Association of single‐point insulin sensitivity estimator index (SPISE) with future cardiovascular outcomes in patients with type 2 diabetes
di: Simin Deng, et al.
Pubblicazione: (2024)

Body roundness index ( BRI ) and obesity‐related anthropometrics: Relationship to visceral adiposity, insulin sensitivity index and cardiometabolic risk
di: Pei Chia Eng, et al.
Pubblicazione: (2025)

L‐aspartate ameliorates diet‐induced obesity by increasing adipocyte energy expenditure
di: Shi‐Yao Guo, et al.
Pubblicazione: (2024)

Body size, insulin sensitivity, metabolic health and risk of cardiovascular disease in Chinese adults: Insights from the China Cardiometabolic Disease and Cancer Cohort (4C) study
di: Chunyan Hu, et al.
Pubblicazione: (2024)

High‐protein vegan and omnivorous diets improve peripheral insulin sensitivity to a similar extent in people with type 2 diabetes
di: Gráinne Whelehan, et al.
Pubblicazione: (2024)

Postoperative insulin requirements in surgical patients receiving fully automated insulin delivery in the hospital
di: Gabija Krutkyte, et al.
Pubblicazione: (2025)

Impact of metabolic and bariatric surgery on weight loss and insulin requirements in type 1 and insulin‐treated type 2 diabetes
di: Kamal Abi Mosleh, et al.
Pubblicazione: (2024)

Metabolically unhealthy adipose tissue is characterized by reductions in mitochondrial size and function
di: Darla DeStephanis, et al.
Pubblicazione: (2025)

Plasma LEAP2 concentration is associated with energy intake and postprandial insulin increase depending on meal size but not weight status in men
di: María F. Andreoli, et al.
Pubblicazione: (2025)

Postprandial time in tight range with faster insulin aspart compared with standard insulin aspart in youth with type 1 diabetes using automated insulin delivery
di: Klemen Dovč, et al.
Pubblicazione: (2025)

Impact of insulin sensitization on metabolic and fertility outcomes in women with polycystic ovary syndrome and overweight or obesity—A systematic review, meta‐analysis, and meta‐regression
di: Suhaniya N. S. Samarasinghe, et al.
Pubblicazione: (2024)

Characterizing insulin dosing behaviour and glycaemic excursions: Development of metrics using connected insulin pen and continuous glucose monitoring
di: Howard Wolpert, et al.
Pubblicazione: (2025)

Cost‐utility analysis of once‐weekly insulin icodec and once‐daily insulin glargine in patients with type 2 diabetes receiving basal‐bolus insulin therapy in China
di: Nan Dai, et al.
Pubblicazione: (2024)

Interactive online calculator for estimation of muscle and hepatic insulin sensitivity in adults with Type 1 diabetes using clinical and research biomarkers
di: Andrzej S. Januszewski, et al.
Pubblicazione: (2026)

Orforglipron, an oral non‐peptide glucagon‐like peptide‐1 receptor agonist, improves markers of β‐cell function and insulin sensitivity in type 2 diabetes
di: Julio Rosenstock, et al.
Pubblicazione: (2025)

Cost‐utility of once‐weekly insulin icodec versus once‐daily basal insulins for type 2 diabetes in China
di: Xichen Tong, et al.
Pubblicazione: (2026)

Sustained caloric restriction potentiates insulin action by activating prostacyclin synthase
di: Carmen Merali, et al.
Pubblicazione: (2024)

The effect of quercetin on adipogenesis, lipolysis, and apoptosis in 3T3‐L1 adipocytes: The role of SIRT1 pathways
di: Mohammad Hasan Maleki, et al.
Pubblicazione: (2024)